Close Menu

EMBL-EBI

EBI researchers find that, in mice, the genetics of one cage mate influences the other's health.

Interviews with leading UK scientists revealed apprehension about losing access to European funding, limitations on freedom of movement, and an exodus of biotechs to the EU.

The portal offers access to genotype, phenotype, and clinical data related to type 2 diabetes as well as computational tools for querying the information. 

Researchers used genomic approaches to search for disease clues in purified cells from ileum or colon biopsies of pediatric inflammatory bowel disease patients.

Researchers from EBI, Georgetown, and others are mapping protein annotations to the human reference genome to it more easily accessible.

CMDL is usingGenestack's platform to evaluate the effectiveness of bone marrow transplants and plans to use it for other oncology tests as well.

The analysis published by Charles Beagrie reports an approximately £20 million return on investment to the scientific community for every £1 million invested.

In a paper published today in Nature Methods, the researchers applied scM&T-seq to profile the transcriptomes and epigenomes of mouse embryonic stem cells.

Nearly a dozen researchers, including the European Bioinformatics Institute's Ewan Birney, share the state of their field at PLOS Medicine.

The method makes it possible to study correlations between multiple genetic variants and multiple phenotypic traits in large cohorts

Pages

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.